HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Alivus Life Sciences Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Alivus Life Sciences Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 563.95 as of 20 May 15:30.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Alivus Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Alivus Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 1029 crore as compare to the Sep '24 revenue of ₹ 1050 crore. This represent the decline of -1.95% The revenue of Alivus Life Sciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 140.71 crore as compare to the Sep '24 ebitda of ₹ 138.35 crore. This represent the growth of 1.71% The ebitda of Alivus Life Sciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 66.31 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Alivus Life Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Alivus Life Sciences Ltd

  • Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
  • The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

News

Akums Drugs hits life high on inking pact with Caregen

Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...

Read more

19 Nov 2024 12:59

News

Akums Drugs & Pharmaceuticals to conduct board meeting

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

06 Nov 2024 15:48

Alivus Life Sciences Ltd News Hub

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

News

Glenmark Life Sciences renamed as Alivus Life Sciences

Glenmark Life Sciences announced its change of identity to Alivus Life Sciences, marking a...

Read more

20 Jan 2025 10:18

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Alivus Life Sciences Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 8,692 Cr while Market cap of Alivus Life Sciences Ltd is 14,052 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd?

As of May 20, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹552.25. On the other hand, Alivus Life Sciences Ltd stock price is INR ₹1145.9.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Alivus Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions